Ataxia Rating Scales-Psychometric Profiles, Natural History and Their Application in Clinical Trials

Saute, Jonas; Donis, Karina; Serrano-Munuera, Carmen; Genis, David; Ramirez, Luís; Mazzetti, Pilar; Pérez, Luis; Latorre, Pilar; Sequeiros, Jorge; Matilla-Dueñas, Antoni; Jardim, Laura
June 2012
Cerebellum;Jun2012, Vol. 11 Issue 2, p488
Academic Journal
We aimed to perform a comprehensive systematic review of the existing ataxia scales. We described the disorders for which the instruments have been validated and used, the time spent in its application, its validated psychometric properties, and their use in studies of natural history and clinical trials. A search from 1997 onwards was performed in the MEDLINE, LILACS, and Cochrane databases. The web sites ClinicalTrials.gov and Orpha.net were also used to identify the endpoints used in ongoing randomized clinical trials. We identified and described the semiquantitative ataxia scales (ICARS, SARA, MICARS, BARS); semiquantitative ataxia and non-ataxia scales (UMSARS, FARS, NESSCA); a semiquantitative non-ataxia scale (INAS); quantitative ataxia scales (CATSYS 2000, AFCS, CCFS and CCFSw, and SCAFI); and the self-performed ataxia scale (FAIS). SARA and ICARS were the best studied and validated so far, and their reliability sustain their use. Ataxia and non-ataxia scores will probably provide a better view of the overall disability in long-term trials and studies of natural history. Up to now, no clear advantage has been disclosed for any of them; however, we recommend the use of specific measurements of gait since gait ataxia is the first significant manifestation in the majority of ataxia disorders and comment on the best scales to be used in specific ataxia forms. Quantitative ataxia scales will be needed to speed up evidence from phase II clinical trials, from trials focused on the early phase of diseases, and for secondary endpoints in phase III trials. Finally, it is worth remembering that estimation of the actual minimal clinically relevant difference is still lacking; this, together with changes in quality of life, will probably be the main endpoints to measure in future therapeutic studies.


Related Articles

  • Identifying relevant studies for systematic reviews. Dickersin, Kay; Scherer, Roberta; Lefebvre, Carol // BMJ: British Medical Journal (International Edition);11/12/94, Vol. 309 Issue 6964, p1286 

    Examines the sensitivity and precision of Medline searching for randomized clinical trials in Baltimore, Maryland. Comparison between Medline searches and Gold standard of randomized clinical trials; Consideration of Gold standards in the meta-analysis; Demonstration of clinical trials for...

  • A Meta-Analysis of the Literature on Distal Radius Fractures. Paksima, Nader; Panchal, Anand; Posner, Martin A.; Green, Steven M.; Mehlman, Charles T.; Hiebert, Rudi // Bulletin of the NYU Hospital for Joint Diseases;2004, Vol. 62 Issue 1/2, p40 

    A structured meta-analysis of the available literature was performed to evaluate the outcome of the treatment of displaced intra-articular fractures of the distal radius. A comprehensive search of Medline using the key words "radius" and "fracture" revealed over 4,000 articles. After limiting...

  • Risk of Hepatic Events in Patients Treated with Vancomycin in Clinical Studies. Yan Chen; Xiao Yan Yang; Michael Zeckel; Killian, Chris; Hornbuckle, Kenneth; Regev, Arie; Voss, Simon // Drug Safety;2011, Vol. 34 Issue 1, p73 

    Background: Routine surveillance of spontaneous reporting data and sub- sequent disproportionality analyses have indicated that the use of vancomycin might be associated with an increased risk of hepatic events. Objective: To conduct a meta-analysis of published randomized controlled clinical...

  • Response to: Practical methods for incorporating summary time-to-event data into meta-analysis. Yu Wang; Tingting Zeng; Wang, Yu; Zeng, Tingting // Trials;2013, Vol. 14 Issue 1, p1 

    A response to and comment on Practical methods for incorporating summary time-to-event data into meta-analysis, by Jayne F Tierney et al.

  • Comparative efficacy and acceptability of seven augmentation agents for treatment-resistant depression: A multiple-treatments meta-analysis. Wang, X.; Huang, S.; Qi, H. B. // South African Journal of Obstetrics & Gynaecology;2014, Vol. 20 Issue 3, p71 

    Background. Treatment-resistant depression (TRD) is a therapeutic challenge for clinicians. Augmentation pharmacotherapy is effective for TRD, but it is still unclear which augmentation agent is most efficacious. Objective. To assess the effects of seven augmentation agents on TRD. Methods. We...

  • Meta-analysis is to analysis as meta-physics is to physics. Speroff, Leon // Contemporary OB/GYN;Jun2007, Vol. 52 Issue 6, p116 

    The author offers insights into the application of meta-analysis on individual clinical trials. He cites several limitations of the statistical method such that the meta-analysis of observational studies requires the authors to make subjective judgments as to which epidemiologic reports can be...

  • Meta-Analysis of Multi-Arm Trials Using Empirical Logistic Transform. Chootrakool, Hathaikan; Jian Qing Shi // Open Medical Informatics Journal;2008, Vol. 2, p112 

    Meta-analysis of multi-arm trials has been used increasingly in recent years. The aim of meta-analysis for multi-arm trials is to combine evidence from all possible similar studies. In this paper we propose normal approximation models by using empirical logistic transform to compare different...

  • Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis. Renehan, A G; Egger, M; Saunders, M P; O'Dwyer, S T // British Journal of Cancer;2/14/2005, Vol. 92 Issue 3, p430 

    A meta-analysis of six randomised trials demonstrated that intensive followup in colorectal cancer was associated with an absolute reduction in all-cause 5-year mortality of 10%(95%confidence interval (CI): 4-16)-however, only two percent (95%CI: 0-5) was attributable to cure from salvage...

  • Review: Population-based screening for abdominal aortic aneurysm reduces cause-specific mortality in older men. Cinà, Claudio S.; Devereaux, P.J. // ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p27 

    This article presents information on a study related to screening for abdominal aortic aneurysm (AAA). 4 randomized controlled trials (RCTs) of population-based screening for AAA in several men, 65 years of age were included. Meta-analysis showed that an invitation to attend AAA screening and a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics